Yoga-Based Cancer Rehabilitation Program

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
No phase specifiedBehavioral study, Supportive careActive18 and overNCI, Other#2000-007
NCI R03 CA88598-01A1, NCT00179348

Trial Description


The purpose of this study is to find out if a Yoga-Based Cancer Rehabilitation Program can help reduce the physical and emotional side effects of living with cancer or its treatment.

Further Study Information

Research on yoga is extensive in both healthy and chronically ill individuals including cardiovascular disease, chronic pain, diabetes, asthma, headache, anxiety and depression. Benefits of yoga include: improved mood, energy, memory, concentration, flexibility, physical fitness, breathing capacity, and decreased pain, blood pressure, and cholesterol. There is paucity of controlled research studies on the effects of yoga for cancer patients. Yoga is an ideal intervention to improve quality of life for patients with cancer because it incorporates elements of relaxation, social support, and exercise, all found to improve quality of life. This randomized-controlled study compares a 12-week yoga intervention to standard care on quality of life among patients with early-stage breast, lung, and colorectal cancer. Quality of life assessments are conducted at baseline, and at one, three, and six month intervals.

Eligibility Criteria

Inclusion Criteria:

  • Diagnosis of Breast Cancer (Stages I, II, or III), Colorectal Cancer (Stages I, II, or III), or Lung Cancer (Stages I, II)
  • Diagnosed with new or recurrent cancer within past 5 years
  • Language is English or Spanish
  • Recovered from surgery and any postoperative complications requiring hospitalization

Exclusion Criteria:

  • Current Yoga Practice >1x month
  • Unable to attend yoga class due to time conflict
  • Advanced cancer with symptomatic pulmonary, skeletal or brain metastases
  • Second Primary cancer that is active
  • ECOG performance status of 3 or 4
  • Seizures
  • Arthritis or muscle pain, if severe enough to interfere with simple Yogic exercises
  • Asthma or difficulty breathing, if severe enough to interfere with ability to perform deep breathing
  • Uncontrolled hypertension
  • Heart condition or problems
  • Current (Uncontrolled) major psychiatric disorder

Trial Contact Information

Trial Lead Organizations/Sponsors

Albert Einstein Cancer Center at Albert Einstein College of Medicine

  • National Cancer Institute
  • Jacob and Valeria Langeloth Foundation
Alyson Moadel, Ph.D., Principal Investigator
Alyson Moadel, Ph.D.
Ph: 718-430-2696

Trial Sites


New York

Albert Einstein Cancer Center at Albert Einstein College of Medicine

Alyson Moadel, Ph.D.
Ph: 718-430-2696

Alyson Moadel, Ph.D.
Principal Investigator

Link to the current record.
NLM Identifier NCT00179348 processed this data on October 20, 2014

Note: Information about this trial is from the database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the record to standardize the names of study sponsors, sites, and contacts. only lists sites that are recruiting patients for active trials, whereas lists all sites for all trials. Questions and comments regarding the presented information should be directed to